Literature DB >> 6381718

Trypanosoma cruzi: quantification and analysis of the infectivity of cloned stocks.

P S Doyle, J A Dvorak, J C Engel.   

Abstract

The infection of bovine embryo skin and muscle cells by trypomastigotes of four Trypanosoma cruzi clones (CA-I/71, /72, Miranda/76, /80) was quantified. Stable and reproducible intra-isolate differences were observed; an almost 70-fold difference in infectivity occurred between clones. The CA-I/71 clone was not susceptible to N-acetyl-D-glucosamine at a concentration that inhibits the infection of vertebrate cells by Ernestina and Y-strain parasites. Eight other monosaccharides that are common constituents of vertebrate cell surface glycoproteins also failed to inhibit the infection of vertebrate cells by the CA-I/71 clone.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381718     DOI: 10.1111/j.1550-7408.1984.tb02961.x

Source DB:  PubMed          Journal:  J Protozool        ISSN: 0022-3921


  8 in total

1.  Trypanosoma cruzi: properties of a clone isolated from CL strain.

Authors:  M T Lima; A M Jansen; E Rondinelli; C R Gattass
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

2.  Two approaches to discovering and developing new drugs for Chagas disease.

Authors:  J H McKerrow; P S Doyle; J C Engel; L M Podust; S A Robertson; R Ferreira; T Saxton; M Arkin; I D Kerr; L S Brinen; C S Craik
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

3.  Variation in antigenic determinants specific to the infective stage of Trypanosoma cruzi.

Authors:  R A Wrightsman; W Leon; J E Manning
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

4.  Oligopeptidase B-dependent signaling mediates host cell invasion by Trypanosoma cruzi.

Authors:  E V Caler; S Vaena de Avalos; P A Haynes; N W Andrews; B A Burleigh
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

5.  Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo.

Authors:  P S Doyle; J Crabb; C Petersen
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

6.  A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection.

Authors:  Patricia S Doyle; Yuan M Zhou; Juan C Engel; James H McKerrow
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

7.  The Trypanosoma cruzi protease cruzain mediates immune evasion.

Authors:  Patricia S Doyle; Yuan M Zhou; Ivy Hsieh; Doron C Greenbaum; James H McKerrow; Juan C Engel
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

8.  Trypanosoma cruzi CYP51 inhibitor derived from a Mycobacterium tuberculosis screen hit.

Authors:  Chiung-Kuang Chen; Patricia S Doyle; Liudmila V Yermalitskaya; Zachary B Mackey; Kenny K H Ang; James H McKerrow; Larissa M Podust
Journal:  PLoS Negl Trop Dis       Date:  2009-02-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.